Eternity Biotech

Executive Summary

Eternity Biotech is a private San Diego-based biotechnology company founded in 2016 with a mission to extend human lifespan through innovative antibody and biologic therapies. While the company's public profile is limited, its focus on life extension places it in the burgeoning longevity sector. No specific pipeline, clinical programs, or financial details have been disclosed, indicating an early, likely preclinical stage. The company appears to be leveraging antibody engineering to target aging pathways, a strategy shared by several peers. However, without concrete data on lead candidates, partnerships, or funding, visibility into its progress is low. The longevity field holds significant promise but is also fraught with scientific and regulatory challenges. Eternity Biotech's ability to advance will depend on securing capital, generating proof-of-concept data, and differentiating itself in a competitive landscape.